BBOT - Latest News
BridgeBio Oncology Therapeutics Inc. (BBOT), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $232.9M. Beta to the broader market is 0.39.
The article list below shows the most recent BBOT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BBOT Headlines
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - Oct 12, 2026
SOUTH SAN FRANCISCO, Calif. , Oct.
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Receives Consensus Rating of “Moderate Buy” from Analysts
defenseworld.net - Oct 8, 2026
BridgeBio Oncology Therapeutics, Inc (NASDAQ: BBOT - Get Free Report) has earned an average rating of "Moderate Buy" from the ten analysts that are pr
Brokerages Set BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Price Target at $22.88
defenseworld.net - Sep 16, 2026
BridgeBio Oncology Therapeutics, Inc (NASDAQ: BBOT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the ten rati
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
globenewswire.com - Sep 8, 2026
SOUTH SAN FRANCISCO, Calif. , Sept.
BBOT to Participate in Upcoming Investor Healthcare Conferences
globenewswire.com - Sep 1, 2026
SOUTH SAN FRANCISCO, Calif. , Sept.
How News Affects BBOT Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BBOT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BBOT news questions
- What is the latest BBOT news headline?
- The most recent BBOT headline (Oct 12, 2026) is "BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BBOT news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BBOT news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BBOT options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.